DK134742B - Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved. - Google Patents

Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved.

Info

Publication number
DK134742B
DK134742B DK17474AA DK17474A DK134742B DK 134742 B DK134742 B DK 134742B DK 17474A A DK17474A A DK 17474AA DK 17474 A DK17474 A DK 17474A DK 134742 B DK134742 B DK 134742B
Authority
DK
Denmark
Prior art keywords
stable
preparation
parenteral administration
solutions containing
administration suitable
Prior art date
Application number
DK17474AA
Other languages
English (en)
Inventor
Gabor Szepesi
Takacsi Nagy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK134742B publication Critical patent/DK134742B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK17474AA 1973-01-15 1974-01-14 Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved. DK134742B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI496A HU166289B (da) 1973-01-15 1973-01-15

Publications (1)

Publication Number Publication Date
DK134742B true DK134742B (da) 1977-01-10

Family

ID=11000913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17474AA DK134742B (da) 1973-01-15 1974-01-14 Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved.

Country Status (13)

Country Link
JP (1) JPS505521A (da)
AT (1) AT332552B (da)
AU (1) AU6354673A (da)
BE (1) BE809693A (da)
CS (1) CS172273B2 (da)
DD (1) DD108460A5 (da)
DE (1) DE2362337A1 (da)
DK (1) DK134742B (da)
FR (1) FR2213768B1 (da)
GB (1) GB1440275A (da)
HU (1) HU166289B (da)
IL (1) IL43814A0 (da)
NL (1) NL7317458A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54125630A (en) * 1978-02-22 1979-09-29 Nippon Zoki Pharmaceutical Co Novel propanone derivative*its manufacture and medical composition containing it as active component

Also Published As

Publication number Publication date
FR2213768B1 (da) 1977-07-01
BE809693A (fr) 1974-05-02
ATA22374A (de) 1976-01-15
FR2213768A1 (da) 1974-08-09
JPS505521A (da) 1975-01-21
NL7317458A (da) 1974-07-17
GB1440275A (en) 1976-06-23
DD108460A5 (da) 1974-09-20
AU6354673A (en) 1975-06-12
CS172273B2 (en) 1976-12-29
HU166289B (da) 1975-02-28
DE2362337A1 (de) 1974-07-18
IL43814A0 (en) 1974-03-14
AT332552B (de) 1976-10-11

Similar Documents

Publication Publication Date Title
DK117587B (da) Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
DK137329B (da) Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater.
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
DK138974B (da) Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DK135454B (da) Analogifremgangsmåde til fremstilling af 2,1,3-benzothiadiazolderivater.
SE7504451L (sv) Asymmetriska, halvgenomtrengliga membraner av polybens-1,3-oxazindioner-(2,3).
NO138615C (no) Anvendelse av et amin for fremstilling av vandige, stabile opploesninger av 1,2-benzisotiazolon
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
NO141655C (no) Konsentrert, flytende saapeopploesning
DK140696B (da) Funktionaliserede adeninderivater til anvendelse til fremstilling af makromolekylære adeninderivater.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK134742B (da) Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
DK370875A (da) Fremgangsmade til fremstilling af insulin, insulin-analoge og -derivater
DK138399B (da) Fremgangsmåde til fremstilling af purpuromycin og derivater deraf.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
CH552043A (de) Stabile, konzentrierte loesungen basischer azofarbstoffe.
DK145781C (da) Analogifremgangsmaade til fremstilling af ditiino(1,4)(2,3-c)pyrrolderivater
DK140670B (da) Analogifremgangsmåde til fremstilling af ergopeptinderivater.
DK134486B (da) Analogifremgangsmåde til fremstilling af 3-hydrazonomethyl-rifamycin-derivater eller 25-desacetyl- eller 16, 17, 18, 19, 28, 29-hexahydroderivater deraf.
DK136652B (da) Fremgangsmåde til fremstilling af thieno-pyridinderivater.
AR211319A1 (es) Procendimiento para preparar derivados de 8-aza-9-oxo(y dioxo)-tia-11,12-secoprostaglandinas
DK134552B (da) Analogifremgangsmåde til fremstilling af substituerede 2H-pyran-2,6(3H)-dionderivater.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment